#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the vulva Fibrous dysplasia of bone Desmoid tumour Dent's disease NTRK gene fusion overexpression Myelodysplastic syndrome with excess blasts Autologous haematopoietic stem cell transplant Pulmonary sarcoidosis Osteosarcoma Microscopic polyangiitis Cutaneous T-cell lymphoma Basal cell naevus syndrome Thrombotic microangiopathy Breast angiosarcoma metastatic Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Basic Information Malignant fibrous histiocytoma – Treatment Primary biliary cholangitis – Diagnostics Factor VIII deficiency – Life with Disease Haemophilia A with anti factor VIII – Diagnostics Arterial tortuosity syndrome – Diagnostics Behcet’s syndrome – Life with Disease Hereditary optic atrophy – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MALIC ACID Tulmimetostat Sirexatamab Telmisartan Oditrasertib ADS-019 Benralizumab Canakinumab Radium Ra 223 Dichloride Rituximab Alectinib Hydrochloride Clofutriben Alks 2680 Etelcalcetide [14C] DC-806 Hexaminolevulinate Treosulfan Bevacizumab Talquetamab Sotalol Hydrochloride More therapies…

    Learn about Your Condition

    Fibrous dysplasia of bone Primary hyperoxaluria Haemolytic uraemic syndrome Dystonic tremor Melanoma recurrent Metastases to liver Malignant peritoneal neoplasm Short stature Triple positive breast cancer T-cell type acute leukaemia Oesophagogastroscopy Systemic scleroderma Burkitt's lymphoma Post procedural infection Myasthenia gravis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of tocilizumab compared to placebo in patients with chronic chondrocalcinosis who did not respond to standard treatments

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chondrocalcinosis
    Investigated Drugs:
    • Sodium Chloride
    • Tocilizumab
    France

  • Study of vitamin D3 (cholecalciferol) as additional treatment for elderly patients with pneumonia or sepsis due to infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    • Pneumonia
    • Sepsis
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • (1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
    • 3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
    France

  • Study of oral TherO2-01S22 with anti-HER2 therapy in patients with metastatic breast cancer

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Breast neoplasm
    Investigated Drugs:
    • Vinorelbine Tartrate
    • Docetaxel
    • Paclitaxel
    France

  • Study of Rosuvastatin Effects on Coronary Artery Plaque Volume in Patients with Stable Chest Pain Using CT Imaging

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Dyslipidaemia
    • Coronary artery disease
    Investigated Drugs:
    • Rosuvastatin
    Hungary

  • Evaluation of triptorelin, estradiol, and testosterone compared to placebo for changes in bone markers in postmenopausal women

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Menopause
    Investigated Drugs:
    • Testosterone
    • Triptorelin
    • Estradiol Hemihydrate
    Denmark
Previous Page
1 … 779 780 781 782 783 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!